#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Renal cell carcinoma Squamous cell carcinoma of the cervix Subdural haematoma Blood iron increased Alagille syndrome Metastases to central nervous system Paraneoplastic neurological syndrome Pustular psoriasis Antithrombin III deficiency Adult T-cell lymphoma/leukaemia refractory Carcinoid tumour Gaucher's disease type III Severe myoclonic epilepsy of infancy Primary immunodeficiency syndrome Kaposi's sarcoma More trials…

    Learn about Rare Diseases

    Choroid melanoma Rhabdomyosarcoma recurrent Brain stem glioma – Diagnostics Synovial sarcoma recurrent – Life with Disease Glomerulonephritis rapidly progressive – Treatment Osteosarcoma recurrent – Basic Information Angelman’s syndrome – Diagnostics Paraneoplastic neurological syndrome – Life with Disease Propionic acidaemia – Life with Disease Encephalitis autoimmune – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BENZYLPENICILLIN PROCAINE Olaparib Mitoxantrone Hydrochloride Wve-006 Cinchocaine Hydrochloride Noradrenaline Tartrate Vx-264 Bicalutamide Prasugrel Ecoo2 SONLICROMANOL HYDROCHLORIDE Mosunetuzumab Iberdomide Abemaciclib Atogepant M1P Dipotassium Salt Iobitridol Clozapine HYDROGEN Sodium Gluconate More therapies…

    Learn about Your Condition

    Osteoporosis postmenopausal Giardiasis Vascular dementia Bacterial prostatitis Leiomyosarcoma recurrent C3 glomerulopathy Hip arthroplasty Cerebral haemorrhage Hepatic neoplasm Hypophosphatasia B-cell lymphoma Fatty acid oxidation disorder Coronary artery bypass Pancreatic neoplasm Acute cardiac event More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effectiveness and Safety of Mitapivat for Children with Pyruvate Kinase Deficiency Receiving Regular Blood Transfusions

    Not recruiting

    3 1
    Investigated Drugs:
    • Mitapivat
    Czechia Denmark The Netherlands Spain

  • Study on Voxelotor for Reducing Hemolysis in Patients with Sickle Cell Disease

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Voxelotor
    France

  • Study on the Effectiveness and Safety of Mitapivat for Patients with Sickle Cell Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Anaemia
    Investigated Drugs:
    • Mitapivat
    Belgium France Germany Italy The Netherlands

  • Study of Talquetamab and Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Daratumumab
    • Teclistamab
    Spain

  • Study on Nivolumab and Tisagenlecleucel for Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia After Treatment Loss

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Tisagenlecleucel
    • Nivolumab
    France

  • Study on Isatuximab, Pomalidomide, Dexamethasone, and Carfilzomib for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Carfilzomib
    • Dexamethasone
    France
Previous Page
1 … 53 54 55 56 57 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!